EUVIMEDEUVIMED entdecken
Crossref

In situ formation of alginic acid‐gold nanohybrids for application in cancer photothermal therapy

André Q Figueiredo, Carolina F Rodrigues, Natanael Fernandes, Ilídio J Correia iD, André F Moreira

Biotechnology Journal · 2024

DOI: 10.1002/biot.202300019 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biotechnology Journal, 2024. Verfasst von André Q Figueiredo und 4 weiteren Autor:innen. Beteiligte Einrichtung: CICS-UBI - Health Sciences Research Centre, Universidade da Beira Interior, Covilhã, Portugal. Hauptthemen laut MEDLINE: Nanoparticles, Metal Nanoparticles, Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 50 Literaturangaben. Gefördert von: Foundation for Science and Technology, European Regional Development Fund.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Gold‐based nanoparticles present excellent optical properties that propelled their widespread application in biomedicine, from bioimaging to photothermal applications. Nevertheless, commonly employed manufacturing methods for gold‐based nanoparticles require long periods and laborious protocols that reduce cost‐effectiveness and scalability. Herein, a novel methodology was used for producing gold‐alginic acid nanohybrids (Au‐Alg‐NH) with photothermal capabilities. This was accomplished by promoting the in situ reduction and nucleation of gold ions throughout a matrix of alginic acid by using ascorbic acid. The results obtained reveal that the Au‐Alg‐NHs present a uniform size distribution and a spike‐like shape. Moreover, the nanomaterials were capable to mediate a temperature increase of ≈11°C in response to the irradiation with a near‐infrared region (NIR) laser (808 nm, 1.7 W cm −2 ). The in vitro assays showed that Au‐Alg‐NHs were able to perform a NIR light‐triggered ablation of cancer cells (MCF‐7), being observed a reduction in the cell viability to ≈27%. Therefore, the results demonstrate that this novel methodology holds the potential for producing Au‐Alg‐NH with photothermal capacity and higher translatability to the clinical practice, namely for cancer therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

NanoparticlesMetal NanoparticlesNeoplasmsAlginic AcidGoldPhotothermal TherapyPhototherapy

Stichwörter der Autor:innen

alginic acidcancergold nanohybridsphotothermal therapy

Substanzen

Alginic AcidGold

Autor:innen und Institutionen

  • CICS-UBI - Health Sciences Research Centre, Universidade da Beira Interior, Covilhã, Portugal.
  • CIEPQPF - Departamento de Engenharia Química, Universidade de Coimbra, Coimbra, Portugal.
  • CPIRN-UDI/IPG - Centro de Potencial e Inovação em Recursos Naturais, Unidade de Investigação para o Desenvolvimento do Interior do Instituto Politécnico da Guarda, Guarda, Portugal.

ORCID-Profile: Ilídio J Correia

Förderung

  • Foundation for Science and Technology
  • European Regional Development Fund

Zitieren

APA

Figueiredo, A. Q., Rodrigues, C. F., Fernandes, N., Correia, I. J., & Moreira, A. F. (2024). In situ formation of alginic acid‐gold nanohybrids for application in cancer photothermal therapy. Biotechnology Journal. https://doi.org/10.1002/biot.202300019

Vancouver

Figueiredo AQ, Rodrigues CF, Fernandes N, Correia IJ, Moreira AF. In situ formation of alginic acid‐gold nanohybrids for application in cancer photothermal therapy. Biotechnology Journal. 2024. doi:10.1002/biot.202300019

BibTeX
@article{Figueiredo2024,
  author = {Figueiredo, André Q and Rodrigues, Carolina F and Fernandes, Natanael and Correia, Ilídio J and Moreira, André F},
  title = {In situ formation of alginic acid‐gold nanohybrids for application in cancer photothermal therapy},
  journal = {Biotechnology Journal},
  year = {2024},
  doi = {10.1002/biot.202300019}
}
Kostenlos starten →